NinePointTwo Capital »

Catalyst Pharmaceutical Partners shares owned by NinePointTwo Capital

Quarter-by-quarter ownership of Catalyst Pharmaceutical Partners (CPRX) shares owned by NinePointTwo Capital from 13F filings

Historical chart of NinePointTwo Capital investment in Catalyst Pharmaceutical Partners

Tip: Access up to 7 years of quarterly data

All positions including Catalyst Pharmaceutical Partners held by NinePointTwo Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Catalyst Pharmaceutical Partners by NinePointTwo Capital

Quarter filed Position value Share count Share price at filing
2023-12-31 $364k 22k 16.78
2023-09-30 $253k 22k 11.67
2023-06-30 $223k 17k 13.43
2022-12-31 $237k 13k 18.55

More positions owned by NinePointTwo Capital

Schwab Strategic Tr Us Tips Etf (SCHP)
Vaneck Etf Trust Jp Mrgan Em Loc (EMLC)
Ishares Tr Tips Bd Etf (TIP)
Dbx Etf Tr Xtrack Usd High (HYLB)
Vanguard Whitehall Fds High Div Yld (VYM)
Invesco Actvely Mngd Etc Optimum Yield (PDBC)
Ishares Tr Select Divid Etf (DVY)
Apollo Global Mgmt (APO)
Ishares Tr Rus Tp200 Gr Etf (IWY)
Apple (AAPL)
Hca Holdings (HCA)
Microsoft Corporation (MSFT)
UnitedHealth (UNH)
Meta Platforms Cl A (META)
Nxp Semiconductors N V (NXPI)

View all positions for NinePointTwo Capital

Top funds holding Catalyst Pharmaceutical Partners

BlackRock
Deerfield Management Company
Vanguard Group
State Street Corporation
Dimensional Fund Advisors
Geode Capital Management
Renaissance Technologies
Henderson Group
Royce & Associates
Jacobs Levy Equity Management
Kennedy Capital Management
T. Rowe Price Associates
Marshall Wace
Charles Schwab Investment Management
Goldman Sachs Group

View all funds holding Catalyst Pharmaceutical Partners